Bivalent Covid booster doses updated for Omicron were just authorized in the US and are already starting to become available: https://www.cnn.com/2022/09/01/health/covid-omicron-booster-explainer-wellness/index.html
Resolves to the percentage of the US population that has been vaccinated with a bivalent Covid booster dose at the end of October. (Percentage of the total US population, not just the eligible US population.) Resolution will be based on CDC (this page https://covid.cdc.gov/covid-data-tracker/#vaccinations_vacc-people-additional-dose-totalpop currently shows several different vaccination stats and will likely add data for bivalent doses in the near future). If data is not available from the CDC, then resolves based on another official source.
Companion question for December 2022:
1,000🏅 Top traders
| # | Name | Total profit |
|---|---|---|
| 1 | Ṁ47 | |
| 2 | Ṁ6 | |
| 3 | Ṁ3 | |
| 4 | Ṁ1 | |
| 5 | Ṁ0 |
CDC shows 22.8M people with a bivalent booster dose. 22.8M / 332M = 6.9%. Resolves to this if I haven't made any errors.
For a baseline: In spring 2022, vaccination rates reached a peak of 500k per day https://covid.cdc.gov/covid-data-tracker/#vaccination-trends. That rate sustained over 2 months would be 30M doses, which would be 10% of the US population. In late 2021, vaccination rates were above 1.5m per day for a couple months, which works out to about 27% of the US population over 2 months. However, both of those include primary vaccinations as well as boosters, while this market counts only bivalent boosters.